COL1A1 and systemic sclerosis: Both incubation with irinotecan and SN38 decreased the expression of COL1A1, COL1A2, MMP1 and ACTA2 genes in dermal fibroblasts of HD and SSc patients, with a statistically significant effect for SN38.